Amphastar Pharmaceuticals, Inc., headquartered in Rancho Cucamonga, California, established in 1996, is a recognized specialty pharmaceutical company that uses state-of-the-art, cGMP compliant facilities to develop, manufacture, and market injectable and inhalation products. In addition to the Corporate Headquarters, Amphastar has five manufacturing facilities located in the United States, China and Europe along with a state-of-the-art New Drug Research Center. Amphastar and its subsidiaries each have their own distinct focus that they skillfully bring together to meet the varied needs of the pharmaceutical industry. We currently produce approximately 15 injectable products while we continue to develop a portfolio of generic and branded products that target large markets with high technical barriers to entry. Amphastar’s long-standing relationship with the major group purchasing organizations and drug wholesalers in the U.S. enables it to establish significant market share upon the introduction of its new products.

For more than half a century, IVC has been producing some of the highest quality dietary supplements for leading retailers in the U.S. - as well as nutritional, prescription and OTC products for contract customers throughout the world. IVC’s ability to deliver on innovation, quality and supply chain efficiency has enabled us to become one of the fastest growing companies in the nutritional market.

Founded in 1895 by the Sisters of Divine Providence, OLLU offers bachelor's, master's and doctoral degrees through weekday, weekend, evening, and online settings in San Antonio, Houston and the Rio Grande Valley (La Feria). Overall enrollment is more than 3,300 undergraduate and graduate students. Academic units include the School of Business and Leadership, the College of Arts and Sciences, the College of Professional Studies, the Worden School of Social Service and the Woolfolk School of Communication Sciences and Disorders. OLLU has more than 24,000 alumni.

An American Vanguard Company (NYSE: AVD). AMVAC® is a solutions provider for global agriculture that is committed to technology, innovation, and sustainability. We focus on four innovation platforms: Proven Chemistries, Precision Agriculture, GreenSolutions™, and Sustainability Solutions for plant and soil health. www.AMVAC.com

Performing specific technical color education ● Lead more than 30 hands­ on seminars of of 3­6 hours for up to 20 participants, coordinating site and logistical accommodations with both Regis and Wella management by email and phone, to ensure rewarding and enriching events.

Dendreon is a commercial-stage biopharmaceutical company and pioneer in the development of immunotherapy. Dendreon’s flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy made from a patient’s own immune cells. More than 40,000 men with advanced prostate cancer have been prescribed PROVENGE in the U.S. since 2010. Dendreon also is evaluating the use of PROVENGE in early-stage prostate cancer, with the hope of curing more men of the disease. Dendreon is headquartered in Seal Beach, Calif.